REPOTRECTINIB

274 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking REPOTRECTINIB:

# Side effect Count
0 DIZZINESS 44
1 DEATH 28
2 NAUSEA 21
3 OFF LABEL USE 19
4 NEUROPATHY PERIPHERAL 18
5 FATIGUE 13
6 ADVERSE EVENT 12
7 PAIN 12
8 MUSCULAR WEAKNESS 11
9 PARAESTHESIA 10
See all common reactions for REPOTRECTINIB

REPOTRECTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MORBILLIVIRUS TEST POSITIVE 1 0.2000
1 BREAST ANGIOSARCOMA METASTATIC 1 0.1250
2 RUBIVIRUS TEST POSITIVE 1 0.0625
3 VARICELLA MENINGITIS 2 0.0400
4 RUBULAVIRUS TEST POSITIVE 1 0.0385
5 GLUTAMATE DEHYDROGENASE INCREASED 1 0.0090
6 PANCREATIC LEAK 1 0.0089
7 ROSEOLOVIRUS TEST POSITIVE 1 0.0082
8 HYPERADRENOCORTICISM 2 0.0073
9 EAR, NOSE AND THROAT DISORDER 1 0.0071
See all enriched reactions for REPOTRECTINIB